43 Participants were randomised to receive subcutaneous semaglutide or placebo, and the semaglutide group had a 24% lower risk of the primary renal outcome (HR 0.76
Having a comprehensive GLP-1 diet plan is essential when you begin your weight loss journey
Nevertheless, prescribers must evaluate each patient individually, considering their complete medical history, current medications, cardiovascular risk factors, and treatment goals
I spent weeks comparing prices across eight Canadian pharmacies, both online and brick-and-mortar, to build the most accurate price comparison available
As microdosing gains traction, clinicians should be aware of the techniques, benefits, risks, and implications associated with this practice